Vaccines and Preventable Diseases:
Combined Tdap Vaccine
Combined Tetanus, Diphtheria and Pertussis (Tdap) Vaccines
Adolescent and Adult Recommendations:
On June 30, 2005 the Advisory Committee on Immunization Practices (ACIP) voted to recommend the routine use of Tdap vaccines in adolescents aged 11–18 years in place of tetanus and diphtheria toxoids (Td) vaccines.
On October 26, 2005 the ACIP voted to recommend routine use of a single dose of Tdap for adults 19-64 years of age to replace the next booster dose of tetanus and diphtheria toxoids vaccine (Td). The ACIP also recommended Tdap for adults who have close contact with infants younger than 12 months of age.
MMWR References
- December 2006 MMWR: Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
- February 2006 MMWR: Preventing Tdap Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines
- april 2009 MMWR: FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Rduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Disease and Vaccine Information
- Tetanus disease and vaccine information
- Diphtheria disease and vaccine information
- Pertussis disease and vaccine information
Pregnancy-related Recommendations:
May 2008 MMWR: Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and their Infants (ACIP Recommendations)
This page last modified on August 11, 2009
Content last reviewed on August 11, 2009
Content Source: National Center for Immunization and Respiratory Diseases
Content last reviewed on August 11, 2009
Content Source: National Center for Immunization and Respiratory Diseases